Media Intelligence for the Pharmaceutical Industry

Yes. We monitor agencies including the FDA, EMA, Health Canada, and MHRA. You’ll receive alerts on approvals, recalls, safety communications, and policy developments. These updates help compliance, legal, and regulatory teams respond fast, maintain accurate documentation, and stay aligned with changing rules. They also provide early insights into market shifts that could affect pipelines or partnerships.

We track traditional and digital media coverage of clinical trials, drug approvals, adverse events, litigation, mergers, regulatory shifts, and commentary from HCPs or patients. Our approach ensures you don’t miss critical mentions across global, regional, or trade media outlets. With comprehensive coverage, you can assess sentiment, anticipate reputational risks, and measure campaign effectiveness more effectively.

Absolutely. We tailor monitoring and reports by product, therapy area, brand, or geography. That means each stakeholder sees only the most relevant content. This customization allows communications, marketing, and medical affairs teams to prioritize insights aligned with their goals. By filtering coverage in this way, your teams save time, avoid irrelevant data, and focus only on strategic intelligence.

We provide real-time alerts and curated analysis to flag coverage that could harm your brand. That means communications and compliance teams can act quickly and consistently. Our analysts provide context around each issue, ensuring leaders understand both risks and opportunities. With proactive alerts, you can prepare talking points, align stakeholders, and engage external audiences before challenges escalate into full-blown crises.

AI-only tools collect large volumes of content, but often lack context. Our analysts enhance machine learning with expert curation. This ensures your insights are timely, relevant, and meaningful. This hybrid approach reduces false positives, eliminates irrelevant results, and highlights stories with the highest impact. The end result is greater confidence in your data and clearer intelligence to guide leadership decisions.

Yes. We offer high-frequency monitoring during launches, safety events, or crises. You’ll receive real-time alerts and custom reports tailored to the situation. During launches, we help you track sentiment, competitor reactions, and media reach. In crisis scenarios, our rapid monitoring provides early warning signs and consistent updates. That way, leadership can respond strategically and your company can maintain credibility with stakeholders.